Trial · NCT06973304
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
NCT06973304, Phase 3, Active not recruiting, Takeda
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome. Trials, record NCT06973304. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06973304
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
- NCT number
- NCT06973304
- Status
- Active not recruiting
- Phases
- Phase 3
- Enrollment
- 13 participants, actual
- Lead sponsor
- Takeda
- Conditions
- Short Bowel Syndrome
- Interventions
- Teduglutide
- First posted
- 2025-05-15
- Last updated
- 2026-09-08
Source ClinicalTrials.gov
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants Who Achieved At Least 20 Percent (%) Reduction From Baseline in Weekly Parenteral Support (PS) Volume at Week 20 and Maintained Through Week 24 | Up to Week 24 | |
| Secondary | Absolute Change From Baseline in Weekly PS Volume up to Week 24 | Baseline up to Week 24 | |
| Secondary | Percent Change From Baseline in Weekly PS Volume up to Week 24 | Baseline up to Week 24 | |
| Secondary | Absolute Change From Baseline in Days Per Week of PS up to Week 24 | Baseline up to Week 24 | |
| Secondary | Percent Change From Baseline in Days Per Week of PS up to Week 24 | Baseline up to Week 24 | |
| Secondary | Number of Participants Who Achieved At Least 20% Reduction From Baseline in Weekly PS Volume at each visit | Up to Week 24 | |
| Secondary | Number of Participants With At Least a 20% Reduction From Baseline in Weekly PS at Week 20 and Maintained Through Week 24 | Baseline, Week 20 and Week 24 | |
| Secondary | Number of Participants With At Least a 2-liter Reduction From Baseline in Weekly PS at Week 20 and Maintained Through Week 24 | Baseline, Week 20 and Week 24 | |
| Secondary | Number of Participants who are able to Completely Wean off of PS support at Week 24 | At Week 24 | |
| Secondary | Time From First Dose to Time of Completely Weaning off of PS Support | Up to Week 24 |
1 to 10 of 23Source ClinicalTrials.gov
See all 23 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06973304
GET https://conductscience.org/api/trials/v1/NCT06973304/registered?page=2